This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities
BMC Cancer Open Access 03 June 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010; 18: 11–22.
Bullinger L, Kronke J, Schon C, Radtke I, Urlbauer K, Botzenhardt U et al. Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis. Leukemia 2010; 24: 438–449.
Rucker FG, Bullinger L, Schwaenen C, Lipka DB, Wessendorf S, Frohling S et al. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization. J Clin Oncol 2006; 24: 3887–3894.
Chen D, Zhang J, Li M, Rayburn ER, Wang H, Zhang R . RYBP stabilizes p53 by modulating MDM2. EMBO Rep 2009; 10: 166–172.
Godin KS, Walbott H, Leulliot N, van Tilbeurgh H, Varani G . The box H/ACA snoRNP assembly factor Shq1p is a chaperone protein homologous to Hsp90 cochaperones that binds to the Cbf5p enzyme. J Mol Biol 2009; 390: 231–244.
Grozdanov PN, Roy S, Kittur N, Meier UT . SHQ1 is required prior to NAF1 for assembly of H/ACA small nucleolar and telomerase RNPs. RNA 2009; 15: 1188–1197.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Bullinger, L., Krönke, J., Gaidzik, V. et al. Comment on ‘Integrative genomic profiling of human prostate cancer’. Leukemia 24, 1970–1972 (2010). https://doi.org/10.1038/leu.2010.194
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2010.194